These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6646393)

  • 1. Phenylethylamine-like properties of baclofen.
    Wolf ME; Keener S; Mathis P; Mosnaim AD
    Neuropsychobiology; 1983; 9(4):219-22. PubMed ID: 6646393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
    Nair NP; Lal S; Schwartz G; Thavundayil JX
    Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baclofen in the treatment of tardive dyskinesia and schizophrenia.
    Simpson GM; Lee JH; Shrivastava RK; Branchey MH
    Psychopharmacol Bull; 1978 Apr; 14(2):16-8. PubMed ID: 349598
    [No Abstract]   [Full Text] [Related]  

  • 4. Baclofen in the treatment of tardive dyskinesia.
    Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G
    Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of baclofen on tardive dyskinesia.
    Gerlach J; Rye T; Kristjansen P
    Psychopharmacology (Berl); 1978 Mar; 56(2):145-51. PubMed ID: 417365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baclofen in tardive dyskinesia patients maintained on neuroleptics.
    Stewart RM; Rollins J; Beckham B; Roffman M
    Clin Neuropharmacol; 1982 Dec; 5(4):365-73. PubMed ID: 6130838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of tardive dyskinesia with baclofen.
    Glazer WM; Moore DC; Bowers MB; Bunney BS; Roffman M
    Psychopharmacology (Berl); 1985; 87(4):480-3. PubMed ID: 3936106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of tardive dystonia.
    Yassa R; Nair V; Dimitry R
    Acta Psychiatr Scand; 1986 Jun; 73(6):629-33. PubMed ID: 2875611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-resistant tardive dyskinesia: a new therapeutic approach.
    Amsterdam J; Mendels J
    Am J Psychiatry; 1979 Sep; 136(9):1197-8. PubMed ID: 474810
    [No Abstract]   [Full Text] [Related]  

  • 11. Baclofen and tardive dyskinesia.
    Feder R; Moore DC
    Am J Psychiatry; 1980 May; 137(5):633-4. PubMed ID: 7369421
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia.
    Lancet; 1979 Sep; 2(8140):447-8. PubMed ID: 89504
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia.
    Korsgaard S
    Acta Psychiatr Scand; 1976 Jul; 54(1):17-24. PubMed ID: 782159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between parkinsonism and tardive dyskinesia.
    Gerlach J
    Am J Psychiatry; 1977 Jul; 134(7):781-4. PubMed ID: 869056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tardive dyskinesia caused by metoclopramide therapy].
    Häggström JE
    Lakartidningen; 1981 Jan; 78(5):361. PubMed ID: 7206956
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-induced "painful legs and moving toes" syndrome: successful treatment with clonazepam and baclofen.
    Sandyk R
    Ital J Neurol Sci; 1990 Dec; 11(6):573-6. PubMed ID: 2081681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.